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OBJECTIVES This study was designed to determine the effect of gender on the prognostic value of exercise
echocardiography.
BACKGROUND Limited information exists regarding gender differences in prognostic value of exercise
echocardiography.
METHODS We obtained follow-up (3.2  1.7 years) in 5,798 consecutive patients who underwent
exercise echocardiography for evaluation of known or suspected coronary artery disease.
RESULTS There were 3,322 men (mean age 62 12 years) and 2,476 women (mean age 62 12 years)
(p  0.7). New or worsening wall motion abnormalities developed with exercise in 35% of
men and 25% of women (p  0.001). Cardiac events, including cardiac death (107 patients)
and nonfatal myocardial infarction (148 patients), occurred in 5.3% of men and 3.1% of
women (p  0.001). Addition of the percentage of ischemic segments to the clinical and rest
echocardiographic model provided incremental information in predicting cardiac events for
both men (X2  137 to 143, p  0.014) and women (X2  72 to 76, p  0.046). By
multivariate analysis, exercise electrocardiographic and exercise echocardiographic predictors
of cardiac events in both men and women were workload and exercise wall motion score
index. There was no significant interaction effect of rest echocardiography (p 0.79), exercise
electrocardiography (p  0.38) or exercise echocardiography (p  0.67) with gender.
CONCLUSIONS Although cardiac events occurred more frequently in men, the incremental value of exercise
echocardiography was comparable in both genders. Of all exercise electrocardiographic and
exercise echocardiographic variables, workload and exercise wall motion score index had the
strongest association with outcome. The results of exercise echocardiography have compara-
ble implications in both men and women. (J Am Coll Cardiol 2002;39:625–31) © 2002 by
the American College of Cardiology
Ischemic heart disease is the most common cause of death
for American men and women (1). In women, the diagnosis
of this disease by exercise electrocardiography is limited by
lower accuracy when compared with men (2–5). The Amer-
ican College of Cardiology/American Heart Association
exercise test guidelines (2) state that “the difficulties posed
by clinical evaluation of women for possible coronary artery
disease (CAD) have led to speculation that stress imaging
approach may be an efficient initial alternative to exercise
electrocardiography in women. . . .”
In women, the accuracy of exercise echocardiography is
higher than the accuracy of exercise electrocardiography
(6,7). However, lower sensitivity and higher specificity of
exercise echocardiography in women compared with men
has been reported (8). Because only a small percentage of
patients undergoing clinically indicated exercise echocardi-
ography are referred for coronary angiography, attempts to
determine the true accuracy of the test are confounded by
post-test referral bias. The usefulness of exercise echocardi-
ography in women might be best established by studying its
prognostic value.
The purposes of the present study were to determine if
gender differences exist in the prognostic value of exercise
echocardiography and to assess the incremental value of
exercise echocardiography in predicting cardiac events in
men and women.
METHODS
Patients. The study was approved by the Institutional
Review Board. From January 1990 to December 1995, a
total of 6,421 patients were referred for clinically indicated
exercise echocardiography for evaluation of known or sus-
pected CAD. Of the patients, 254 (4%) had inadequate
echocardiographic images and 136 patients (2%) refused to
participate in research. Among the remaining 5,798 pa-
tients, follow-up was obtained in 5,728 (95%); these make
up the study population.
Data regarding patients’ cardiac history and risk factors
were entered in our computerized database at the time of
the exercise echocardiogram. Hypercholesterolemia was de-
fined as total cholesterol200 mg/dl or use of a cholesterol-
lowering agent. Hypertension was defined as blood pressure
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140/90 mm Hg or use of antihypertensive medication.
Diabetes mellitus was defined by the presence of a fasting
blood glucose concentration140 mg/dl or requirement for
insulin or orally administered hypoglycemic agents.
Exercise echocardiography protocol. All patients under-
went symptom-limited treadmill exercise testing. Standard
blood pressure and 12-channel electrocardiographic moni-
toring were performed. Exercise was performed according
to the Bruce protocol in 3,003 men (90%) and 2,126 women
(86%), the Naughton protocol in 190 women (8%) and 150
men (5%), and modified Bruce protocol in 169 men (5%)
and 160 women (6%) (overall p  0.001).
Two-dimensional echocardiographic images were ob-
tained from the parasternal and apical windows at rest and
immediately after exercise. Studies were recorded on video-
tape. The standard views were also digitized and stored in
quad screen format (9).
Exercise echocardiographic interpretation. Both digi-
tized and videotape-recorded images were used for inter-
pretation (10). Regional wall motion was assessed semi-
quantitatively by an experienced echocardiographer (11)
blind to clinical information. Wall motion at rest and with
exercise was scored 1 through 5 according to a 16-segment
model (12). Wall motion score index (WMSI) was calcu-
lated at rest and with exercise as the sum of the segmental
scores divided by the number of visualized segments mul-
tiplied by 100%. The development of new or worsening wall
motion was considered indicative of myocardial ischemia. A
wall motion abnormality present at rest and unchanged with
exercise was classified as fixed. Exercise echocardiography
results were defined as abnormal if ischemia or fixed wall
motion abnormalities were present. The percentage of
segments that were abnormal was calculated as abnormal
segments divided by the number of visualized segments
multiplied by 100%. The percentage of ischemic segments
was calculated similarly. Ejection fraction at rest was mea-
sured using a previously validated modification of the
method of Quinones et al. (13) or by visual estimation (14).
The exercise electrocardiogram (ECG) was positive for
ischemia if there was horizontal or downsloping ST-
segment depression of 1 mm at 80 ms after the J point,
nondiagnostic if there was baseline ST-segment deviation
or negative for ischemia in the absence of these criteria.
Workload was measured in metabolic equivalents (METs).
Follow-up. Follow-up was obtained by mailed question-
naires, scripted telephone interviews and review of medical
records. Events were verified by contacting the patients’
primary physicians and reviewing medical records and death
certificates.
The end points considered were cardiac events, including
nonfatal myocardial infarction (MI) and cardiac death.
Sudden death occurring without another explanation was
included as cardiac death. Myocardial infarction was a
clinical diagnosis, based on the usual clinical, electrocardio-
graphic and enzymatic criteria. Patients who had coronary
revascularization (angioplasty or coronary artery bypass
surgery) before other events were censored at the time of
revascularization.
Statistical analysis. Continuous variables were reported as
mean  standard deviation and categorical variables as
percentages. Comparisons between men and women were
based on the Wilcoxon rank-sum test for continuous vari-
ables and Pearson’s chi-square test for categorical variables.
For outcome analyses, a time to first event approach was
used. Survival free of the end point of interest was estimated
by the Kaplan-Meier method. Univariable and multivariable
association of clinical and exercise echocardiographic vari-
ables with the end points were assessed using the Cox
proportional hazards model. Variables were selected in a
stepwise forward selection manner, with entry and retention
in the model set at a significance level of 0.05. All interac-
tion terms were tested jointly by using the global change in
the model log likelihood as the test statistic. The results of
the univariable and multivariable analyses were summarized
as risk ratios with corresponding 95% confidence intervals
(CIs). For a continuous multivariate predictor, a dichoto-
mized cut-off value of the multivariate predictor that re-
sulted in the largest change in the likelihood function was
used to classify patients into risk groups. This was done
separately for each gender.
The incremental value of exercise echocardiography was
assessed in two modeling steps. The first step consisted of
fitting a multivariable model of clinical, rest echocardio-
graphic and exercise electrocardiographic data. Variables
selected from this first step were then used as baseline risk
factors, and exercise echocardiographic variables were added
in a stepwise forward selection manner. Entry and retention
were set at a significant level of 0.05 for each of the three
modeling steps.
RESULTS
Study group. Of the 5,798 patients, 1,632 underwent
stress echocardiography for evaluation of known CAD,
3,294 for the evaluation of chest pain or dyspnea, 136 for
preoperative cardiac risk assessment, 222 because of nondi-
agnostic or positive exercise ECG and 521 for evaluation of
risk factors. There were 3,322 men (57%) and 2,476 women
(43%) . The mean age was 62  12 years for men and 62 
12 years for women (p  0.7). The baseline characteristics
of the patients are summarized in Table 1. Men more often
had typical angina; women more often had atypical chest
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
ECG  electrocardiogram
METs  metabolic equivalents
MI  myocardial infarction
RR  relative risk
WMSI  wall motion score index
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pain. Risk factors of smoking, hypertension and family
history differed significantly in men and women.
Exercise echocardiography. The exercise electrocardio-
graphic and exercise echocardiographic characteristics are
summarized in Table 2. The rest and exercise echocardio-
grams were normal in 1,514 men (46%) and 1,657 women
(67%); in 549 men (17%) and 411 women (17%) the
echocardiogram was normal at rest but ischemic with
exercise; in 641 men (19%) and 193 women (8%) there were
wall motion abnormalities at rest without ischemia; in 617
men (19%) and 215 women (9%) there were wall motion
abnormalities at rest and ischemia with exercise (overall p
0.001).
Outcomes. During a median follow-up of 3.2  1.7 years,
there were 255 cardiac events. Cardiac death occurred in 74
men and 33 women and nonfatal MI in 105 men and 43
women. Causes of cardiac death included sudden death in
12 men and 7 women, MI in 33 men and 10 women and
congestive heart failure in 16 men and 6 women. Of the
patients, 178 (31%) underwent revascularization before any
cardiac event and were censored. For cardiac death, the
estimated one-, three- and five-year survival rates were
significantly worse for men (99.5%, 98.0% and 96.7%,
respectively) than for women (99.8%, 99.2% and 97.6%,
respectively) (p  0.04). For cardiac events, event-free
survival was also worse for men (98.6%, 95.1% and 90.4%,
Table 1. Population Characteristics
Characteristics
Men
(n  3,322)
Women
(n  2,476) p Value
Symptoms, n (%)
Asymptomatic 1,570 (47) 786 (32) 0.001
Typical angina 719 (22) 419 (17)
Atypical chest pain 1,033 (31) 1,271 (51)
Clinical characteristics, n (%)
Current smoking 470 (14) 286 (12) 0.004
Diabetes mellitus 335 (10) 227 (9) 0.2
Hypertension 1,487 (45) 1,109 (45) 0.98
Hypercholesterolemia 1,754 (53) 1,409 (57) 0.002
Family history of CAD 1,178 (36) 1,034 (42)  0.00001
Prior PTCA 438 (13) 155 (6) 0.001
Prior CABG 591 (18) 127 (5) 0.001
History of MI 818 (25) 278 (11) 0.001
Beta-blocker therapy 835 (25) 556 (22) 0.02
Baseline ECG, n (%)
Q-wave on ECG 700 (21) 243 (10)  0.00001
ST/T abnormalities 1,346 (41) 967 (39) 0.26
Normal 1,337 (40) 1,251 (51) 0.001
CABG coronary artery bypass graft; CAD coronary artery disease; ECG electrocardiogram; MImyocardial infarction;
PTCA  percutaneous transluminal coronary angioplasty.
Table 2. Exercise Echocardiographic Characteristics
Characteristics (Mean  SD)
Men
(n  3,322)
Women
(n  2,476) p Value
Functional aerobic capacity (%) 101  30 112  35  0.00001
Workload (METs) 9.1  3.0 8.0  2.5  0.00001
Baseline heart rate (beats/min) 72  13 78  14  0.00001
Exercise heart rate (beats/min) 143  25 148  24  0.00001
Baseline systolic blood pressure (mm Hg) 135  20 135  21 0.77
Exercise systolic blood pressure (mm Hg) 180  34 175  28  0.00001
Baseline diastolic blood pressure (mm Hg) 83  13 82  12 0.006
Exercise diastolic blood pressure (mm Hg) 87  20 86  15 0.0003
Angina pectoris 371 (11) 195 (8)  0.0001
Exercise electrocardiogram
Positive 746 (22) 388 (16)  0.00001
Negative 1758 (53) 1527 (62)
Nondiagnostic 818 (25) 561 (23)
Rest ejection fraction 56  10 59  7  0.00001
Rest WMSI 1.2  0.4 1.1  0.2  0.00001
Exercise WMSI 1.3  0.4 1.1  0.3  0.00001
Ischemica by echo 1166 (35) 626 (25) 0.0001
METs  metabolic equivalents; WMSI  wall motion score index.
627JACC Vol. 39, No. 4, 2002 Arruda-Olson et al.
February 20, 2002:625–31 Exercise Echocardiography: Is There a Gender Difference?
respectively) than for women (99.5%, 97.6% and 94.9%,
respectively) (p  0.0001).
Predictors of cardiac events. Univariable associations with
cardiac events are shown in Table 3; all of these variables
were considered as potential predictors for multivariable
models. Positive exercise ECG and angina during the
exercise test were not predictive. Multivariable predictors of
cardiac events are reported in Table 4.
The independent predictors for events in both men and
women included history of MI, workload and exercise
WMSI. In men, an increase of 1 MET in workload was
associated with a reduction of 10% in the risk of events. In
women, an increase of 1 MET in workload was associated
with a reduction of 14%. In men, a 0.5-unit increase in
exercise WMSI carried a 52% increase in the risk of events.
In women, this change was associated with a 48% increase
in the risk of events. The survival free of cardiac events for
both genders according to workload and exercise WMSI is
shown in Figures 1 and 2, respectively. Workload 6
METs and exercise WMSI 1.25 were the best discrimi-
nators of increased risk for both men and women. The
relationship of exercise WMSI and cardiac events per
person-year of follow-up is shown in Figure 3.
For men, the independent predictors for cardiac death
were: workload (relative risk [RR]  0.78; 95% CI 0.71 to
0.85; p  0.0001); rest ejection fraction (RR  0.53; 95%
CI 0.45 to 0.64 per 10 units of change; p  0.0001); and
change in WMSI from rest to exercise (RR 1.67; 95% CI
1.15 to 2.43 per 0.5 unit change; p  0.01). Independent
predictors in women were: typical angina (RR  2.60; 95%
CI 1.27 to 5.35; p  0.009); previous MI (RR  3.42; 95%
CI 1.68 to 6.97; p  0.007); diabetes mellitus (RR  2.26;
95% CI 1.04 to 4.89; p  0.04); and workload (RR  0.82;
95% CI 0.70 to 0.95; p  0.10).
Incremental value of exercise echocardiography. For
both genders, the clinical, rest echocardiogram and exercise
electrocardiographic predictors of cardiac events included
age, diabetes mellitus, typical angina, prior MI, rest ejection
fraction and workload (men: X2  137; women: X2  72).
Addition of the exercise echocardiographic variable, per-
centage of ischemic segments, improved both models (men:
X2  143, p  0.014; women: X2  76, p  0.046). There
was no significant interaction effect of rest echocardiography
(p  0.79), exercise electrocardiography (p  0.38) or
exercise echocardiography (p  0.67) with gender, indicat-
ing comparable risk stratification for both genders.
DISCUSSION
In this study of 5,798 patients, the treadmill exercise
echocardiogram provided significant incremental value
when compared with clinical, rest echocardiographic and
exercise electrocardiographic variables for predicting cardiac
death and cardiac events in both genders. Although cardiac
events were more common in men, there was no interaction
effect of gender with predictors for events, suggesting that
exercise echocardiography as a method for assessment of
prognosis is comparable in both men and women. The best
exercise echocardiographic predictor of events was the
Table 3. Univariable Predictors of Cardiac Events
Variable
Men Women
RR 95% CI p RR 95% CI p
History of angina 1.69 1.23–2.33 0.001 1.92 1.14–3.23 0.01
Hypertension 1.47 1.09–1.97 0.01 1.74 1.10–2.74 0.02
Prior MI 3.37 2.51–4.52 0.0001 6.13 3.88–9.67 0.0001
Diabetes mellitus 2.51 1.73–3.63 0.0001 2.49 1.42–4.40 0.002
Age, per decade 1.48 1.22–1.63 0.0001 1.63 1.22–1.97 0.0001
Prior coronary revascularization* 2.21 1.65–2.97 0.0001 4.65 2.91–7.43 0.0001
Q waves on rest ECG 2.71 2.02–3.66 0.0001 3.68 2.22–6.09 0.0001
Rest ejection fraction† 0.60 0.54–0.66 0.0001 0.54 0.43–0.66 0.0001
Rest WMSI‡ 1.96 1.72–2.24 0.0001 2.41 1.88–3.09 0.0001
Workload (METs)§ 0.83 0.79–0.87 0.001 0.79 0.71–0.87 0.0001
Ischemia by echo 2.00 1.49–2.69 0.0001 2.18 1.38–3.46 0.0009
Exercise % abnormal segments 1.75 1.58–1.93 0.0001 1.68 1.39–2.00 0.0001
% Ischemic segments 1.71 1.42–2.04 0.0001 1.71 1.33–2.24 0.0001
Exercise WMSI‡ 1.95 1.73–2.20 0.0001 2.14 1.71–2.66 0.0001
*Either percutaneous transluminal coronary angioplasty or coronary artery bypass surgery; †per 10 unit charge; ‡per 0.5 unit change; §per 1 MET change; per 25%, or four of
16 segments.
CI  confidence interval; ECG  electrocardiogram; METs  metabolic equivalents; MI  myocardial infarction; RR  risk ratio; WMSI  wall motion score index.
Table 4. Multivariable Predictors of Cardiac Events
(Cox Regression Analysis) in Patients Undergoing Exercise
Stress Echocardiography
Variable RR 95% CI p Value
Men
Prior MI 1.90 1.37–2.63 0.0001
Diabetes mellitus 1.76 1.21–2.57 0.003
Workload (METs) 0.90 0.85–0.95 0.0002
Exercise WMSI* 1.53 1.32–1.77 0.0001
Women
Prior MI 3.75 2.23–6.29 0.0001
Workload (METs) 0.86 0.78–0.95 0.002
Exercise WMSI* 1.49 1.14–1.94 0.003
*Per 0.5 unit charge.
Abbreviations as in Table 3.
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exercise WMSI, an indicator of the extent and severity of
exercise-induced ischemia.
Detection of CAD in women. Noninvasive detection of
CAD is challenging in women, in part because of the lower
prevalence of disease (15). Because of the lower pretest
probability of disease in women, tests are more often false
positive. The exercise electrocardiogram has been shown to
be less accurate in women than in men (2–5). Differences in
the prevalence of multivessel CAD and prior MI (16–18),
differences in exercise capacity (16) and microvascular func-
tion and in the prevalence of syndrome X and mitral valve
prolapse (2) may account for these distinctions. These
difficulties have led to the suggestion that stress imaging
may be the preferred strategy in women (7). However,
Figure 1. Survival free of cardiac death and myocardial infarction are shown in men and women, with exercise capacity 6 metabolic equivalent (METs)
and 6 METs.
Figure 2. Survival free of cardiac death and myocardial infarction are shown in men and women, with exercise wall motion score index (WMSI) 1.25
and 1.25.
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intrinsic gender differences have been noted with exercise
radionuclide angiography (19). Breast artifact is a recog-
nized difficulty of nuclear perfusion imaging (20).
Stress echocardiography has been recommended as a
cost-effective approach to the diagnosis of CAD in women
(7). However, in several large studies, the accuracy for
detection of angiographic disease (7,8,21,22) has varied.
When test referral bias is considered, the positive predictive
value and adjusted sensitivity are lower in women than in
men (8). Because test results influence the decision whether
to perform coronary angiography, with only 9% of the
population undergoing stress echocardiography subse-
quently referred to angiography, the utility of the test is
difficult to discern (8). Therefore, this study was undertaken
to examine the outcomes of all patients undergoing exercise
echocardiography.
Current study. In our study, women presented less often
with typical angina, were less likely to have had prior MI or
prior coronary revascularization and less often had electro-
cardiographic evidence of ischemia. Wall motion score
index, at rest and with stress, was lower in women. Cardiac
events occurred less frequently in women. These differences
are compatible with the lower prevalence and lesser severity
of CAD in women (15,16). Despite these differences, the
clinical, exercise electrocardiographic and echocardiographic
predictors of cardiac events and cardiac death were very
similar in men and women. The clinical variable prior MI
was an independent predictor for events in both genders.
This variable has been described as a predictor of the
presence of multivessel CAD (18). In the current study, an
increase in workload was associated with decreased risk of
cardiac events and cardiac death in both men and women.
Similarly, other investigators using exercise electrocardiog-
raphy (23–25) as well as exercise imaging tests (26,27) have
reported that a higher workload was associated with a
reduction in the risk of events in both genders.
The presence of myocardial ischemia detected by exercise
echocardiography was previously reported as a predictor of
cardiac events in women (28). In the present study, the
exercise WMSI and the percentage of ischemic segments
detected by exercise were independent predictors of events
for both genders. These echocardiographic variables reflect
the extent and severity of CAD and were superior to the
dichotomous variable, ischemia. We have previously re-
ported satisfactory agreement between experienced observ-
ers for scoring of the 16 segments at rest and with stress
(29). Thus, efforts should be made to quantify the extent of
ischemia by scoring the individual segments.
Study limitations. In our population, exercise echocardio-
graphic results were used in managing patients; this may
have reduced the prognostic value of the test. Therefore, an
analysis was performed using only MI and cardiac death as
end points, because the decision for revascularization might
be most influenced by test results. Follow-up was available
for only 95% of patients. Lastly, baseline characteristics
differed in men and women. However, the intent of this
study was to describe a large consecutive series of men and
women referred for clinically indicated exercise echocardi-
ography.
CONCLUSIONS
Exercise echocardiography provides independent prognostic
information for both men and women that is incremental to
clinical, rest echocardiographic and exercise electrocardio-
graphic data. Of all exercise electrocardiographic and exer-
cise echocardiographic variables, workload and exercise
WMSI had the strongest association with outcome. Al-
though cardiac events occurred more frequently in men, the
Figure 3. The relationship of cardiac events per person-year of follow-up is plotted against exercise wall motion score index.
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incremental prognostic value of exercise echocardiography
was comparable in both genders.
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